Garvan Institute of Medical Research
Darlinghurst, New South Wales, 2010, Australia
NCT Number: NCT02501343
The purpose of this study is to test the effect of increasing the body pH acutely with an alkaline medication (sodium bicarbonate, NaHCO3, sodibic) on glucose metabolism post meal in non diabetic subjects with normal renal function.
The investigators aim to determine whether there is an acute reduction in venous blood pH following a typical Western-style (high acid load) breakfast in healthy men and women, and whether this effect is attenuated by the concurrent administration of an alkaline medication. The effect on glucose metabolism, hunger/satiety and arterial stiffness post meal will be assessed.
Looking for future studies?
Notify Me22 year–65 year
All sexes
Interventional
Not applicable
Darlinghurst, New South Wales, 2010, Australia
The aim of the study is to test the effect of increasing the body pH acutely with an alkali (NaHCO3) prior to a high acid load meal on glucose metabolism in non-diabetic men and women.
This is a double-blind placebo-controlled randomised study with a crossover design.
Study Procedures:
Two (2) meal studies will be performed 1 to 2 weeks apart. Studies will include collecting fasting blood to assess circulating glucose, insulin, C-peptide, free fatty acids, glucagon-like peptide-1, acid/base markers, including electrolytes (EUC) and venous blood pH. Participants will then be either administered sodibic (1680 mg) or matching placebo and a standardised Western style/high acid load meal. Investigators and participants will be blinded to the intervention. Blood will be drawn every 15 min in the first hour and then every 30 min for 3 hours in total. Arterial stiffness and appetite score will be evaluated at ½ h intervals.
Sample size: 30
sample size calculation: To detect a difference in area under the curve (AUC) of venous blood pH with a paired crossover design, 32 individuals will be required with statistical power 1-β>0.8 (allowing for drop-out).
statistical considerations: Differences between AUC of outcome measures post sodium bicarbonate vs. placebo will be tested using paired t-tests. Two-way repeated measure ANOVA tests will be conducted to assess differences in the response to the meal with sodium bicarbonate vs. placebo.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Sodium bicarbonate 1680 mg will be administered prior to the meal
Other names: Sodibic capsules (Aspen Australia, NSW, Australia)
Sodibic-matching placebo (Stenlake Compounding Chemist, NSW, Australia) will be administered prior to the meal on a different day 1 to 2 weeks apart
Time frame: Baseline (fasting) and 3 hours post meal
The investigators aim is to determine whether venous blood pH decreases after a high acid load meal, and whether this effect is attenuated by administration of sodium bicarbonate prior to a mixed meal study
Time frame: Baseline (fasting) and 3 hours post meal
Postprandial glucose excursion will be compared between sodium bicarbonate and placebo
Time frame: Baseline (fasting) and 3 hours post meal
Postprandial insulin excursion will be compared between sodium bicarbonate and placebo
Time frame: Baseline (fasting) and 3 hours post meal
Postprandial arterial stiffness (measured by the augmentation index derived from Sphygmocore, Atcor Medical, Australia) will be compared between sodium bicarbonate and placebo
Time frame: Baseline (fasting) and 3 hours post meal
Postprandial hunger and satiety will be compared between sodium bicarbonate and placebo
Garvan Institute of Medical Research
Other
Acronym: ADIS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03461510
Body Weight, Diabetes Mellitus
Jacksonville, Florida, United States
View Trial DetailsNCT04423302
Diabetes Mellitus, Diabetes Mellitus, Type 2
Botevgrad, Bulgaria
View Trial DetailsNCT05277558
Body Weight, Brain Structure
St Louis, Missouri, United States
View Trial DetailsNCT05852054
Cardiovascular Diseases, Diabetes Mellitus
Chicago, Illinois, United States
View Trial Details